Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MBRX | VRAX | PPBT | ||
Company | Moleculin Biotech CS | Virax Biolabs Group Limited | Purple Biotech Ltd ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.8000 | 1.7900 | 3.40 | ||
High | 1.8900 | 1.9287 | 3.49 | ||
Low | 1.6700 | 1.7000 | 3.31 | ||
Last | 1.6700 | 1.7500 | 3.42 | ||
Change | -0.1400 | -0.1400 | -0.03 | ||
% Change | -7.73% | -7.41% | -0.87% | ||
Volume | 59,200 | 382,100 | 112,000 | ||
20-Day Average Volume | 49,175 | 369,370 | 2,753,400 | ||
Previous Close | 1.8100 | 1.8900 | 3.45 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.4050 | 1.8505 | 4.04 | ||
20-Day Raw Stochastic | 0.00% | 27.23% | 11.88% | ||
20-Day Relative Strength | 34.83% | 47.02% | 46.80% | ||
Weighted Alpha | -78.65 | -77.64 | -88.45 | ||
Today's Opinion | 88% Sell | 32% Sell | 72% Sell | ||
Previous Opinion | 88% Sell | 16% Sell | 72% Sell | ||
Last Month's Opinion | 40% Sell | 16% Buy | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -28.02% since 12/13/24 | +11.46% since 12/13/24 | -10.70% since 12/13/24 | ||
Low | 1.6700 on 12/20/24 | 1.5143 on 12/16/24 | 3.31 on 12/20/24 | ||
High | 2.2900 on 12/16/24 | 2.3800 on 12/18/24 | 4.22 on 12/16/24 | ||
1-Month | |||||
%Chg | -37.45% since 11/20/24 | -6.91% since 11/20/24 | +38.46% since 11/20/24 | ||
Low | 1.6700 on 12/20/24 | 1.5143 on 12/16/24 | 2.00 on 11/22/24 | ||
High | 3.1000 on 12/11/24 | 2.3800 on 12/18/24 | 13.95 on 12/02/24 | ||
3-Month | |||||
%Chg | -29.54% since 09/20/24 | -28.28% since 09/20/24 | -50.36% since 09/20/24 | ||
Low | 1.6700 on 12/20/24 | 1.4600 on 10/18/24 | 2.00 on 11/22/24 | ||
High | 3.3300 on 11/14/24 | 3.6200 on 10/23/24 | 13.95 on 12/02/24 | ||
6-Month | |||||
%Chg | -55.82% since 06/20/24 | +1.74% since 06/20/24 | -64.90% since 06/20/24 | ||
Low | 1.6700 on 12/20/24 | 0.9541 on 08/05/24 | 2.00 on 11/22/24 | ||
High | 4.7070 on 07/18/24 | 8.9999 on 08/19/24 | 13.95 on 12/02/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 5,329 | 5,658 | 4,550 | ||
Shares Outstanding, K | 3,191 | 3,233 | 1,331 | ||
Annual Sales | 0 | 160,000 | 0 | ||
Annual Net Income | -29,770,000 | -6,730,000 | -19,880,000 | ||
Last Quarter Sales | 0 | N/A | 0 | ||
Last Quarter Net Income | -10,590,000 | N/A | -6,830,000 | ||
60-Month Beta | 1.87 | 1.84 | 1.12 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.09 on 11/08/24 | N/A | -1.37 on 11/15/24 | ||
Latest Earnings Date | 11/08/24 | 11/19/24 | 11/19/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |